Healthy Volunteers

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Tolerability of Oral Ubrogepant Administered Intermittently for 8 Weeks to Healthy Participants

Participants must meet the following criteria

  • Male or female volunteers 18-50 years of age

Study Visits

  • 1 in-house stay of 1 night/2 days
  • 15 follow up visits


  • Up to $3,780 for time and travel